Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$5K Sell
115
-2,604
-96% -$106K 0.24% 119
2016
Q4
$109K Buy
2,719
+94
+4% +$3.63K 0.52% 62
2016
Q3
$102K Sell
2,625
-248
-9% -$9.36K 0.5% 65
2016
Q2
$99K Buy
2,873
+14
+0.5% +$485 0.48% 58
2016
Q1
$99K Buy
2,859
+1,563
+121% +$54.5K 0.43% 79
2015
Q4
$50K Buy
1,296
+814
+169% +$31.7K 0.21% 142
2015
Q3
$19K Buy
+482
New +$19.1K 0.08% 176

Other funds holding HOLX

New York Life Trust's HOLX Position: Q1 2017 in Review

New York Life Trust reduced its Hologic (HOLX) stake by 96% in Q1 2017, selling an estimated $106K and leaving 115 shares worth $5K. The position accounts for 0.24% of the portfolio, ranked #119.

New York Life Trust first reported a position in HOLX in Q3 2015 and has held it in 7 quarters since. The position peaked at $109K in Q4 2016. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

  • New York Life Trust held 115 shares of Hologic worth $5K as of Q1 2017.
  • New York Life Trust sold 2,604 Hologic shares in Q1 2017, an estimated $106K.
  • Hologic made up 0.24% of New York Life Trust's portfolio in Q1 2017, its #119 holding.
  • New York Life Trust first reported a position in Hologic in Q3 2015 and has held it in 7 quarters since.
  • New York Life Trust's Hologic position peaked at $109K in Q4 2016.
  • 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.